* Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected
to show a
rise in quarterly revenue when it reports results on May 10
(estimated).
* The Framingham Massachusetts-based company is expected to
report a 5.4% increase in revenue to $410 thousand from $388.99
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Xenetic Biosciences
Inc
is for a loss of 11 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated May 8 at 18:31 GMT. All
figures in US dollars unless otherwise stated